查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1913460

智慧医疗设备市场机会、成长要素、产业趋势分析及2026年至2035年预测

Smart Medical Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035
出版日期: | 出版商: Global Market Insights Inc. | 英文 160 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球智慧医疗设备市场预计到 2025 年将达到 616 亿美元，到 2035 年将达到 1952 亿美元，年复合成长率为 11.8%。

智慧医疗设备市场-IMG1

这一增长主要受糖尿病、气喘等慢性病患病率上升以及对居家医疗解决方案和远端患者监护(RPM) 设备需求不断增长的推动。远端医疗和数位健康平台的扩展，以及物联网、人工智慧和云端整合等技术的进步，正在推动智慧医疗设备的普及。穿戴式和微型化设备、预防性照护和居家医疗模式等趋势也进一步推动了市场需求。雅培、苹果、Medtronic、罗氏和飞利浦等领导企业正致力于地域扩张、产品创新、提高产品可负担性以及与医疗服务提供者建立合作关係，以巩固其市场地位。健康意识的提高以及向个人化、即时病患监测的转变，也显着促进了该行业的成长。

市场覆盖范围
开始年份 2025
预测年份 2026-2035
起始值 616亿美元
预测金额 1952亿美元
复合年增长率 11.8%

预计到2025年，诊断和监测设备领域将占据69.8%的市场。此领域包括连续血糖监测仪（CGM）、穿戴式心电图贴片、智慧血压计和脉动式血氧监测仪系统。这些设备能够即时持续撷取生理数据，并将其传输至连网平台进行分析。技术提供者与医疗机构之间的合作，使得病患监测更加便捷高效，进一步推动了该领域的成长。

预计到2025年，慢性病管理市场规模将达183亿美元。用于慢性病管理的智慧型装置整合了穿戴式感测器、家庭监测装置和药物依从性系统，用于追踪生命征象、症状和治疗方法使用情况。即时数据收集使临床医生和患者能够评估风险评分，有效管理多种疾病，从而支持长期照护并改善患者预后。

预计到2025年，北美智慧医疗设备市占率将达到34.8%。该地区的成长主要得益于完善的医疗保健体系、慢性病高发、数位医疗技术的广泛应用以及有利的报销政策。远端医疗基础设施也进一步推动了该地区智慧设备的普及，使北美成为智慧医疗解决方案创新和成长的关键市场。

目录

第一章调查方法和范围

第二章执行摘要

第三章业界考察

  • 生态系分析
  • 产业影响因素
    • 司机
      • 糖尿病、气喘和其他疾病的发生率呈上升趋势
      • 快速发展的医疗设备产业
      • 网路普及率的提高和巨量资料应用的增加
      • 即时数据驱动的诊断和治疗方法正变得越来越重要
    • 产业潜在风险与挑战
      • 隐私问题
      • 低收入和中等收入国家基础设施不足
  • 成长潜力分析
  • 监管环境
  • 救赎方案
  • 技术格局
  • 定价分析
  • 未来市场趋势
  • 供应商情况
  • 併购活动
  • 波特五力分析
  • PESTEL 分析
  • 差距分析

第四章 竞争情势

  • 介绍
  • 企业矩阵分析
  • 公司市占率分析
  • 竞争定位矩阵
  • 战略仪錶板

第五章 依产品类型分類的市场估算与预测，2021-2032年

  • 诊断和监测设备
    • 血糖值监测仪
    • 心率监测器
    • 脉动式血氧监测仪系统
    • 血压监测仪
    • 酒精测试仪
    • 其他诊断和监测设备
  • 治疗设备
    • 携带式氧气浓缩机和人工呼吸器
    • 胰岛素帮浦
    • 助听器
    • 其他医疗器材
  • 其他产品类型

第六章 依最终用途分類的市场估计与预测，2021-2032年

  • 医院
  • 居家医疗环境
  • 其他用途

7. 2021-2032年按分销管道分類的市场估算与预测

  • 实体店面
  • 电子商务

第八章 2021-2032年各地区市场估算与预测

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国

第九章：公司简介

  • Abbott
  • Apple
  • Biobeat
  • Boston Scientific Corporation
  • Dexcom
  • F Hoffmann-La Roche
  • Fitbit
  • Medtronic
  • NeuroMetrix
  • Novo Nordisk
  • Omron Corporation
  • SAMSUNG
  • VitalConnect
  • West Pharmaceutical Services
简介目录
Product Code: 1969

The Global Smart Medical Devices Market was valued at USD 61.6 billion in 2025 and is estimated to grow at a CAGR of 11.8% to reach USD 195.2 billion by 2035.

Smart Medical Devices Market - IMG1

The growth is fueled by the rising prevalence of chronic conditions such as diabetes and asthma, coupled with the increasing demand for home healthcare solutions and remote patient monitoring (RPM) devices. Expansion of telemedicine and digital health platforms, alongside technological advancements in IoT, AI, and cloud-based integrations, are driving the adoption of smart medical devices. Trends such as wearable and miniaturized devices, preventive care, and hospital-at-home models are further boosting market demand. Leading players such as Abbott, Apple, Medtronic, Roche, and Philips are focusing on geographic expansion, product innovation, affordability, and collaboration with healthcare providers to strengthen market presence. Rising health awareness and the shift toward personalized, real-time patient monitoring are significantly contributing to industry growth.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$61.6 Billion
Forecast Value$195.2 Billion
CAGR11.8%

The diagnostic and monitoring devices segment held 69.8% share in 2025. This segment includes continuous glucose monitors (CGMs), wearable ECG patches, smart blood pressure monitors, and pulse oximeters. These devices continuously collect physiological data in real time and transmit it to connected platforms for analysis. Partnerships between technology providers and healthcare organizations are expected to drive further growth in this category by enhancing the accessibility and efficiency of patient monitoring.

The chronic disease management segment reached USD 18.3 billion in 2025. Smart devices for chronic disease management integrate wearable sensors, home monitoring equipment, and medication adherence systems to track vital signs, symptoms, and therapy usage. Real-time data collection allows clinicians and patients to assess risk scores and manage multiple conditions effectively, supporting long-term treatment and improving patient outcomes.

North America Smart Medical Devices Market held a 34.8% share in 2025. Regional growth is driven by a well-established healthcare system, high incidence of chronic diseases, widespread use of digital health technologies, and favorable reimbursement policies. The availability of health insurance and advanced telehealth infrastructure further supports the adoption of smart devices in the region, positioning North America as a leading market for innovation and growth in smart healthcare solutions.

Key players operating in the Global Smart Medical Devices Market include Abbott, Apple, Biobeat Medical, Boston Scientific, Dexcom, Fitbit, Masimo, Medtronic, NeuroMetrix, Novo Nordisk, OMRON Healthcare, Philips, Roche, SAMSUNG, Shenzhen Ztsense Hi Tech, SmartCardia, VitalConnect, Vital Health Ring, West Pharmaceutical Services, and WS Audiology. Companies in the Global Smart Medical Devices Market are focusing on multiple strategies to strengthen their market position. They invest heavily in research and development to launch innovative, miniaturized, and wearable solutions that integrate AI, IoT, and cloud platforms. Geographic expansion allows access to emerging markets with rising healthcare demands. Strategic collaborations with hospitals, clinics, and telemedicine providers enhance device adoption and distribution. Companies are also prioritizing affordability, regulatory compliance, and real-time data capabilities to improve patient engagement.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of diabetes, asthma and other diseases
      • 3.2.1.2 Booming medical device industry
      • 3.2.1.3 Increasing internet penetration rate and adoption of big data
      • 3.2.1.4 Rising importance of real time data driven approach for diagnostics and treatment
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Privacy concerns
      • 3.2.2.2 Lack of suitable infrastructure in low- and middle-income countries
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Reimbursement scenario
  • 3.6 Technological landscape
  • 3.7 Pricing analysis
  • 3.8 Future market trends
  • 3.9 Supplier landscape
  • 3.10 M&A activities
  • 3.11 Porter's analysis
  • 3.12 PESTEL analysis
  • 3.13 Gap analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Diagnostic and monitoring devices
    • 5.2.1 Blood glucose monitors
    • 5.2.2 Heart rate monitors
    • 5.2.3 Pulse oximeters
    • 5.2.4 Blood pressure monitors
    • 5.2.5 Breathalyzers
    • 5.2.6 Other diagnostic and monitoring devices
  • 5.3 Therapeutic devices
    • 5.3.1 Portable oxygen concentrators and ventilators
    • 5.3.2 Insulin pumps
    • 5.3.3 Hearing aid
    • 5.3.4 Other therapeutic devices
  • 5.4 Other product types

Chapter 6 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Hospitals
  • 6.3 Homecare settings
  • 6.4 Other End Use

Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Brick & mortar
  • 7.3 E-commerce

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 Abbott
  • 9.2 Apple
  • 9.3 Biobeat
  • 9.4 Boston Scientific Corporation
  • 9.5 Dexcom
  • 9.6 F Hoffmann-La Roche
  • 9.7 Fitbit
  • 9.8 Medtronic
  • 9.9 NeuroMetrix
  • 9.10 Novo Nordisk
  • 9.11 Omron Corporation
  • 9.12 SAMSUNG
  • 9.13 VitalConnect
  • 9.14 West Pharmaceutical Services